Pharmaceutical Technology12h
Risk adjusted net present value: What is the current valuation of Novo Nordisk’s Amycretin?
Amycretin is a synthetic peptide commercialized by Novo Nordisk, with a leading Phase II program in Obesity. According to Globaldata, it is involved in 8 clinical trials, of which 3 were completed, 4 ...
Hosted on MSN3h
Manhattan Corp, Novo Resources team up to probe Tibooburra for gold
Nanocap and highly illiquid explorer Manhattan Corporation (ASX:MHC) has struck a farm-in deal with Novo Resources (ASX:NVO) ...
devdiscourse5h
Health Headlines: Legal Battles, Breakthroughs, and Controversies Unveiled
Catalent's acquisition by Novo Holdings faces regulatory updates. UK sees a preference for Mounjaro over Wegovy. This image ...
ENDPOINTS NEWS7h
FTC OKs No­vo-Catal­ent deal in ma­jor win for No­vo Nordisk’s GLP-1 man­u­fac­tur­ing
FTC approves Novo Holdings' $16.5B Catalent acquisition. Deal includes selling 3 facilities to Novo Nordisk for $11B, despite ...
Oil spills into Kerch Strait after Russian tanker damaged in storm
A Russian oil tanker carrying thousands of tons of oil products split apart during a heavy storm on Sunday (December 15), ...
South Korea's acting president moves to reassure allies
South Korea's acting president, Han Duck-soo, spoke with U.S. President Joe Biden on Sunday (December 15) to calm worries ...